[{"Assets_0_Q3_USD":284400000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-76747000.0,"NetIncomeLoss_1_Q3_USD":-31723000.0,"NetIncomeLoss_3_Q3_USD":-99514000.0,"StockholdersEquity_0_Q3_USD":179395000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":37366000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":102343000.0,"Ticker":"NVTA","CIK":"1501134","name":"INVITAE CORP","OfficialName":"Invitae Corporation Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1411245815.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20181107"}]